机构：[1]Department of PET-CT/MR Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.[2]Department of Emergency, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Cancer Center of Yunnan Province, Kunming, Yunnan, China.[3]Department of Information Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical Cancer Center of Yunnan Province, Kunming, Yunnan, China.[4]Department of Hepatobiliary Surgery, The First People's Hospital of Kunming City & Ganmei Affiliated Hospital of Kunming Medical University, Kunming, China.
This study was supported by the National Natural Science
Foundation of China (No. 81960496), Yunnan Fundamental
Research Projects (No. 202101AT070050), Xing Dian Ying Cai
Support Plan.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区医学
小类|3 区肿瘤学
最新[2025]版：
大类|3 区医学
小类|4 区肿瘤学
第一作者：
第一作者机构：[1]Department of PET-CT/MR Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Li Jindan,Fu Chaojiang,Zhao Sheng,et al.The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions[J].Frontiers In Oncology.2023,13:920896.doi:10.3389/fonc.2023.920896.
APA：
Li Jindan,Fu Chaojiang,Zhao Sheng,Pu Yongzhu,Yang Fake...&Chen Long.(2023).The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions.Frontiers In Oncology,13,
MLA：
Li Jindan,et al."The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions".Frontiers In Oncology 13.(2023):920896
